BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 31335328)

  • 1. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.
    Hosein AN; Huang H; Wang Z; Parmar K; Du W; Huang J; Maitra A; Olson E; Verma U; Brekken RA
    JCI Insight; 2019 Jul; 5(16):. PubMed ID: 31335328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
    Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
    Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
    Huang H; Brekken RA
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.
    Roe JS; Hwang CI; Somerville TDD; Milazzo JP; Lee EJ; Da Silva B; Maiorino L; Tiriac H; Young CM; Miyabayashi K; Filippini D; Creighton B; Burkhart RA; Buscaglia JM; Kim EJ; Grem JL; Lazenby AJ; Grunkemeyer JA; Hollingsworth MA; Grandgenett PM; Egeblad M; Park Y; Tuveson DA; Vakoc CR
    Cell; 2017 Aug; 170(5):875-888.e20. PubMed ID: 28757253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Alterations in Pancreatic Cancer Metastasis.
    Wang SS; Xu J; Ji KY; Hwang CI
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.
    Öhlund D; Handly-Santana A; Biffi G; Elyada E; Almeida AS; Ponz-Sarvise M; Corbo V; Oni TE; Hearn SA; Lee EJ; Chio II; Hwang CI; Tiriac H; Baker LA; Engle DD; Feig C; Kultti A; Egeblad M; Fearon DT; Crawford JM; Clevers H; Park Y; Tuveson DA
    J Exp Med; 2017 Mar; 214(3):579-596. PubMed ID: 28232471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.
    Arnes L; Liu Z; Wang J; Maurer C; Sagalovskiy I; Sanchez-Martin M; Bommakanti N; Garofalo DC; Balderes DA; Sussel L; Olive KP; Rabadan R
    Gut; 2019 Mar; 68(3):499-511. PubMed ID: 29440233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages.
    Kemp SB; Steele NG; Carpenter ES; Donahue KL; Bushnell GG; Morris AH; The S; Orbach SM; Sirihorachai VR; Nwosu ZC; Espinoza C; Lima F; Brown K; Girgis AA; Gunchick V; Zhang Y; Lyssiotis CA; Frankel TL; Bednar F; Rao A; Sahai V; Shea LD; Crawford HC; Pasca di Magliano M
    Life Sci Alliance; 2021 Jun; 4(6):. PubMed ID: 33782087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma.
    Lo A; Li CP; Buza EL; Blomberg R; Govindaraju P; Avery D; Monslow J; Hsiao M; Puré E
    JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mucus production programme promotes classical pancreatic ductal adenocarcinoma.
    Tonelli C; Yordanov GN; Hao Y; Deschênes A; Hinds J; Belleau P; Klingbeil O; Brosnan E; Doshi A; Park Y; Hruban RH; Vakoc CR; Dobin A; Preall J; Tuveson DA
    Gut; 2024 May; 73(6):941-954. PubMed ID: 38262672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer.
    Topalovski M; Hagopian M; Wang M; Brekken RA
    J Biol Chem; 2016 Oct; 291(42):22244-22252. PubMed ID: 27531748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
    Storz P; Crawford HC
    Gastroenterology; 2020 Jun; 158(8):2072-2081. PubMed ID: 32199881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer.
    Foley K; Rucki AA; Xiao Q; Zhou D; Leubner A; Mo G; Kleponis J; Wu AA; Sharma R; Jiang Q; Anders RA; Iacobuzio-Donahue CA; Hajjar KA; Maitra A; Jaffee EM; Zheng L
    Sci Signal; 2015 Aug; 8(388):ra77. PubMed ID: 26243191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
    Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
    Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment.
    Helms E; Onate MK; Sherman MH
    Cancer Discov; 2020 May; 10(5):648-656. PubMed ID: 32014869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.
    Pérez-Mancera PA; Rust AG; van der Weyden L; Kristiansen G; Li A; Sarver AL; Silverstein KA; Grützmann R; Aust D; Rümmele P; Knösel T; Herd C; Stemple DL; Kettleborough R; Brosnan JA; Li A; Morgan R; Knight S; Yu J; Stegeman S; Collier LS; ten Hoeve JJ; de Ridder J; Klein AP; Goggins M; Hruban RH; Chang DK; Biankin AV; Grimmond SM; ; Wessels LF; Wood SA; Iacobuzio-Donahue CA; Pilarsky C; Largaespada DA; Adams DJ; Tuveson DA
    Nature; 2012 Apr; 486(7402):266-70. PubMed ID: 22699621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
    Ciernikova S; Earl J; García Bermejo ML; Stevurkova V; Carrato A; Smolkova B
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advanced glycation end-product N
    Menini S; Iacobini C; de Latouliere L; Manni I; Ionta V; Blasetti Fantauzzi C; Pesce C; Cappello P; Novelli F; Piaggio G; Pugliese G
    J Pathol; 2018 Jun; 245(2):197-208. PubMed ID: 29533466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.